nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Liothyronine—hypothyroidism	0.203	0.336	CbGbCtD
Sucralfate—ALB—Levothyroxine—hypothyroidism	0.203	0.336	CbGbCtD
Sucralfate—ALB—Liotrix—hypothyroidism	0.198	0.328	CbGbCtD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0167	0.134	CbGpPWpGaD
Sucralfate—Phlebitis—Liothyronine—hypothyroidism	0.016	0.226	CcSEcCtD
Sucralfate—Venous thrombosis—Liotrix—hypothyroidism	0.0127	0.179	CcSEcCtD
Sucralfate—Fluid overload—Liotrix—hypothyroidism	0.0111	0.156	CcSEcCtD
Sucralfate—FGG—adrenal cortex—hypothyroidism	0.0109	0.0541	CbGeAlD
Sucralfate—FGB—heart—hypothyroidism	0.00813	0.0404	CbGeAlD
Sucralfate—Extravasation—Liotrix—hypothyroidism	0.00788	0.111	CcSEcCtD
Sucralfate—FGG—adrenal gland—hypothyroidism	0.00786	0.039	CbGeAlD
Sucralfate—FGB—cardiovascular system—hypothyroidism	0.00767	0.0381	CbGeAlD
Sucralfate—EGF—Differentiation Pathway—TPO—hypothyroidism	0.00733	0.0589	CbGpPWpGaD
Sucralfate—FGG—female gonad—hypothyroidism	0.00733	0.0364	CbGeAlD
Sucralfate—FGB—gonad—hypothyroidism	0.00697	0.0346	CbGeAlD
Sucralfate—FGA—heart—hypothyroidism	0.00696	0.0346	CbGeAlD
Sucralfate—FGA—cardiovascular system—hypothyroidism	0.00657	0.0326	CbGeAlD
Sucralfate—FGG—testis—hypothyroidism	0.0065	0.0323	CbGeAlD
Sucralfate—FGG—liver—hypothyroidism	0.00615	0.0305	CbGeAlD
Sucralfate—FGB—Complement and Coagulation Cascades—CLTC—hypothyroidism	0.00611	0.0491	CbGpPWpGaD
Sucralfate—FGB—blood—hypothyroidism	0.00607	0.0301	CbGeAlD
Sucralfate—FGA—gonad—hypothyroidism	0.00596	0.0296	CbGeAlD
Sucralfate—FGA—pituitary gland—hypothyroidism	0.00582	0.0289	CbGeAlD
Sucralfate—Phlebitis—Liotrix—hypothyroidism	0.00579	0.0816	CcSEcCtD
Sucralfate—FGB—female gonad—hypothyroidism	0.00566	0.0281	CbGeAlD
Sucralfate—Body temperature increased—Liothyronine—hypothyroidism	0.00536	0.0756	CcSEcCtD
Sucralfate—FGA—blood—hypothyroidism	0.00519	0.0258	CbGeAlD
Sucralfate—EGF—heart—hypothyroidism	0.00508	0.0252	CbGeAlD
Sucralfate—FGB—testis—hypothyroidism	0.00502	0.0249	CbGeAlD
Sucralfate—FGA—female gonad—hypothyroidism	0.00484	0.0241	CbGeAlD
Sucralfate—EGF—cardiovascular system—hypothyroidism	0.0048	0.0238	CbGeAlD
Sucralfate—FGB—liver—hypothyroidism	0.00475	0.0236	CbGeAlD
Sucralfate—FGF2—Differentiation Pathway—TPO—hypothyroidism	0.00464	0.0373	CbGpPWpGaD
Sucralfate—FGF2—heart—hypothyroidism	0.00449	0.0223	CbGeAlD
Sucralfate—EGF—Arf6 signaling events—TSHR—hypothyroidism	0.00437	0.0351	CbGpPWpGaD
Sucralfate—EGF—gonad—hypothyroidism	0.00435	0.0216	CbGeAlD
Sucralfate—FGA—testis—hypothyroidism	0.0043	0.0213	CbGeAlD
Sucralfate—EGF—pituitary gland—hypothyroidism	0.00425	0.0211	CbGeAlD
Sucralfate—FGA—liver—hypothyroidism	0.00406	0.0202	CbGeAlD
Sucralfate—FGA—cerebellum—hypothyroidism	0.00397	0.0197	CbGeAlD
Sucralfate—FGF2—Endochondral Ossification—THRA—hypothyroidism	0.00392	0.0315	CbGpPWpGaD
Sucralfate—EGF—adrenal gland—hypothyroidism	0.00379	0.0188	CbGeAlD
Sucralfate—EGF—blood—hypothyroidism	0.00379	0.0188	CbGeAlD
Sucralfate—FGF2—pituitary gland—hypothyroidism	0.00375	0.0186	CbGeAlD
Sucralfate—EGF—thyroid gland—hypothyroidism	0.00366	0.0182	CbGeAlD
Sucralfate—EGF—female gonad—hypothyroidism	0.00354	0.0176	CbGeAlD
Sucralfate—FGF2—adrenal gland—hypothyroidism	0.00335	0.0166	CbGeAlD
Sucralfate—FGF2—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00325	0.0261	CbGpPWpGaD
Sucralfate—FGF2—thyroid gland—hypothyroidism	0.00323	0.016	CbGeAlD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00318	0.0255	CbGpPWpGaD
Sucralfate—EGF—testis—hypothyroidism	0.00314	0.0156	CbGeAlD
Sucralfate—FGF2—female gonad—hypothyroidism	0.00312	0.0155	CbGeAlD
Sucralfate—EGF—liver—hypothyroidism	0.00297	0.0147	CbGeAlD
Sucralfate—EGF—cerebellum—hypothyroidism	0.0029	0.0144	CbGeAlD
Sucralfate—FGF2—testis—hypothyroidism	0.00277	0.0137	CbGeAlD
Sucralfate—Body temperature increased—Levothyroxine—hypothyroidism	0.00263	0.0371	CcSEcCtD
Sucralfate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00263	0.0371	CcSEcCtD
Sucralfate—FGF2—cerebellum—hypothyroidism	0.00256	0.0127	CbGeAlD
Sucralfate—Oedema—Liotrix—hypothyroidism	0.00245	0.0346	CcSEcCtD
Sucralfate—Infection—Liotrix—hypothyroidism	0.00244	0.0343	CcSEcCtD
Sucralfate—FGA—Amyloids—PRL—hypothyroidism	0.00239	0.0192	CbGpPWpGaD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00234	0.0188	CbGpPWpGaD
Sucralfate—EGF—Signaling events mediated by PTP1B—PRL—hypothyroidism	0.00211	0.0169	CbGpPWpGaD
Sucralfate—Body temperature increased—Liotrix—hypothyroidism	0.00194	0.0273	CcSEcCtD
Sucralfate—ALB—heart—hypothyroidism	0.00176	0.00873	CbGeAlD
Sucralfate—FGF2—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.00154	0.0124	CbGpPWpGaD
Sucralfate—ALB—Transport of organic anions—AVP—hypothyroidism	0.0015	0.0121	CbGpPWpGaD
Sucralfate—EGF—Stabilization and expansion of the E-cadherin adherens junction—IGF1—hypothyroidism	0.00142	0.0114	CbGpPWpGaD
Sucralfate—FGB—Platelet degranulation—IGF1—hypothyroidism	0.00139	0.0112	CbGpPWpGaD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00139	0.0112	CbGpPWpGaD
Sucralfate—FGG—Platelet degranulation—IGF1—hypothyroidism	0.00136	0.0109	CbGpPWpGaD
Sucralfate—FGA—Platelet degranulation—IGF1—hypothyroidism	0.00136	0.0109	CbGpPWpGaD
Sucralfate—FGB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.00132	0.0106	CbGpPWpGaD
Sucralfate—ALB—adrenal gland—hypothyroidism	0.00131	0.00651	CbGeAlD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.0013	0.0105	CbGpPWpGaD
Sucralfate—FGA—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.0013	0.0104	CbGpPWpGaD
Sucralfate—FGG—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.0013	0.0104	CbGpPWpGaD
Sucralfate—EGF—Differentiation Pathway—IGF1—hypothyroidism	0.00128	0.0103	CbGpPWpGaD
Sucralfate—EGF—Ceramide signaling pathway—IGF1—hypothyroidism	0.00128	0.0103	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00128	0.0103	CbGpPWpGaD
Sucralfate—EGF—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00122	0.00982	CbGpPWpGaD
Sucralfate—EGF—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00115	0.00922	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—IGF1—hypothyroidism	0.0011	0.00883	CbGpPWpGaD
Sucralfate—ALB—testis—hypothyroidism	0.00108	0.00539	CbGeAlD
Sucralfate—FGF2—Integrins in angiogenesis—VAV3—hypothyroidism	0.00106	0.0085	CbGpPWpGaD
Sucralfate—ALB—liver—hypothyroidism	0.00103	0.00509	CbGeAlD
Sucralfate—FGB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.001	0.00805	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000981	0.00788	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000981	0.00788	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—PRL—hypothyroidism	0.000893	0.00717	CbGpPWpGaD
Sucralfate—EGF—Platelet degranulation—IGF1—hypothyroidism	0.00085	0.00683	CbGpPWpGaD
Sucralfate—EGF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000817	0.00657	CbGpPWpGaD
Sucralfate—EGF—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.00081	0.00651	CbGpPWpGaD
Sucralfate—FGF2—Differentiation Pathway—IGF1—hypothyroidism	0.000809	0.0065	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000809	0.0065	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000785	0.00631	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—VAV3—hypothyroidism	0.000777	0.00624	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000774	0.00622	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—SH2B3—hypothyroidism	0.000752	0.00604	CbGpPWpGaD
Sucralfate—FGF2—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000748	0.00601	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—SH2B3—hypothyroidism	0.000737	0.00592	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—SH2B3—hypothyroidism	0.000737	0.00592	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—VAV3—hypothyroidism	0.000731	0.00588	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000731	0.00588	CbGpPWpGaD
Sucralfate—FGF2—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000726	0.00583	CbGpPWpGaD
Sucralfate—FGF2—Integrins in angiogenesis—IGF1—hypothyroidism	0.000651	0.00523	CbGpPWpGaD
Sucralfate—FGF2—Endochondral Ossification—IGF1—hypothyroidism	0.000643	0.00517	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000617	0.00495	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000612	0.00492	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000604	0.00485	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000604	0.00485	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CLTC—hypothyroidism	0.000579	0.00465	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—PRL—hypothyroidism	0.000565	0.00454	CbGpPWpGaD
Sucralfate—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000557	0.00447	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000517	0.00416	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—VAV3—hypothyroidism	0.000516	0.00415	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—VAV3—hypothyroidism	0.000506	0.00406	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—VAV3—hypothyroidism	0.000506	0.00406	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—VAV3—hypothyroidism	0.000498	0.004	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000494	0.00397	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—VAV3—hypothyroidism	0.000492	0.00395	CbGpPWpGaD
Sucralfate—FGF2—IGF1R signaling cascade—IGF1—hypothyroidism	0.000481	0.00387	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—VAV3—hypothyroidism	0.000463	0.00372	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000463	0.00372	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—SH2B3—hypothyroidism	0.00046	0.00369	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CLTC—hypothyroidism	0.000432	0.00347	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—IGF1—hypothyroidism	0.000425	0.00342	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000424	0.0034	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00038	0.00305	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000377	0.00303	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CLTC—hypothyroidism	0.000371	0.00298	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CLTC—hypothyroidism	0.000366	0.00294	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CLTC—hypothyroidism	0.000364	0.00292	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CLTC—hypothyroidism	0.000364	0.00292	CbGpPWpGaD
Sucralfate—EGF—Immune System—CLTC—hypothyroidism	0.000351	0.00282	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TRH—hypothyroidism	0.000321	0.00258	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IGF1—hypothyroidism	0.000318	0.00255	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VAV3—hypothyroidism	0.000316	0.00254	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—VAV3—hypothyroidism	0.000315	0.00253	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000315	0.00253	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TRH—hypothyroidism	0.000314	0.00253	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TRH—hypothyroidism	0.000314	0.00253	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IGF1—hypothyroidism	0.000311	0.0025	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IGF1—hypothyroidism	0.000311	0.0025	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TSHB—hypothyroidism	0.000286	0.0023	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TSHR—hypothyroidism	0.000286	0.0023	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—VAV3—hypothyroidism	0.000284	0.00228	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TSHB—hypothyroidism	0.00028	0.00225	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TSHB—hypothyroidism	0.00028	0.00225	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TSHR—hypothyroidism	0.00028	0.00225	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TSHR—hypothyroidism	0.00028	0.00225	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000268	0.00215	CbGpPWpGaD
Sucralfate—FGA—Disease—PRL—hypothyroidism	0.000265	0.00213	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SH2B3—hypothyroidism	0.000255	0.00205	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SH2B3—hypothyroidism	0.00025	0.00201	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SH2B3—hypothyroidism	0.00025	0.00201	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CLTC—hypothyroidism	0.000227	0.00182	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CLTC—hypothyroidism	0.000222	0.00179	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VAV3—hypothyroidism	0.000204	0.00164	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TRH—hypothyroidism	0.000196	0.00158	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—IGF1—hypothyroidism	0.000196	0.00158	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IGF1—hypothyroidism	0.000194	0.00156	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000193	0.00155	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PRL—hypothyroidism	0.000189	0.00152	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000187	0.0015	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PRL—hypothyroidism	0.000185	0.00149	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PRL—hypothyroidism	0.000185	0.00149	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—VAV3—hypothyroidism	0.00018	0.00144	CbGpPWpGaD
Sucralfate—EGF—Immune System—PRL—hypothyroidism	0.000179	0.00144	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VAV3—hypothyroidism	0.000175	0.00141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TSHR—hypothyroidism	0.000175	0.00141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TSHB—hypothyroidism	0.000175	0.00141	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VAV3—hypothyroidism	0.000171	0.00138	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VAV3—hypothyroidism	0.000171	0.00138	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AVP—hypothyroidism	0.000169	0.00135	CbGpPWpGaD
Sucralfate—EGF—Immune System—VAV3—hypothyroidism	0.000165	0.00133	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AVP—hypothyroidism	0.000165	0.00133	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AVP—hypothyroidism	0.000165	0.00133	CbGpPWpGaD
Sucralfate—EGF—Disease—PRL—hypothyroidism	0.000165	0.00133	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00016	0.00128	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SH2B3—hypothyroidism	0.000156	0.00125	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000152	0.00122	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CLTC—hypothyroidism	0.000144	0.00115	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000141	0.00114	CbGpPWpGaD
Sucralfate—ALB—Metabolism—IYD—hypothyroidism	0.00013	0.00105	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TRH—hypothyroidism	0.000124	0.000998	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000119	0.00096	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PRL—hypothyroidism	0.000116	0.000929	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRL—hypothyroidism	0.000113	0.00091	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—POMC—hypothyroidism	0.000112	0.0009	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ATP5O—hypothyroidism	0.000111	0.000891	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TSHB—hypothyroidism	0.000111	0.000889	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TSHR—hypothyroidism	0.000111	0.000889	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—POMC—hypothyroidism	0.00011	0.000882	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—POMC—hypothyroidism	0.00011	0.000882	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF1—hypothyroidism	0.000108	0.000866	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VAV3—hypothyroidism	0.000107	0.00086	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SH2B3—hypothyroidism	0.000106	0.000853	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF1—hypothyroidism	0.000106	0.000848	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF1—hypothyroidism	0.000106	0.000848	CbGpPWpGaD
Sucralfate—FGF2—Immune System—VAV3—hypothyroidism	0.000105	0.000841	CbGpPWpGaD
Sucralfate—FGF2—Disease—PRL—hypothyroidism	0.000104	0.00084	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPO—hypothyroidism	0.000104	0.000838	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AVP—hypothyroidism	0.000103	0.000828	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SH2B3—hypothyroidism	9.86e-05	0.000793	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.66e-05	0.000776	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	8.7e-05	0.000699	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.71e-05	0.00062	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRL—hypothyroidism	7.32e-05	0.000588	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VAV3—hypothyroidism	7.28e-05	0.000585	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—POMC—hypothyroidism	6.85e-05	0.00055	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VAV3—hypothyroidism	6.77e-05	0.000544	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1—hypothyroidism	6.59e-05	0.000529	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AVP—hypothyroidism	6.52e-05	0.000524	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	6.07e-05	0.000488	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TSHB—hypothyroidism	4.83e-05	0.000388	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF1—hypothyroidism	4.48e-05	0.00036	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—POMC—hypothyroidism	4.33e-05	0.000348	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3C2A—hypothyroidism	4.3e-05	0.000346	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.24e-05	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1—hypothyroidism	4.17e-05	0.000335	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC5A5—hypothyroidism	3.61e-05	0.00029	CbGpPWpGaD
Sucralfate—ALB—Metabolism—POMC—hypothyroidism	1.89e-05	0.000152	CbGpPWpGaD
